Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03682289
Title Phase II Trial of AZD6738 Alone and in Combination With Olaparib
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

clear cell renal cell carcinoma

transitional cell carcinoma

pancreatic ductal adenocarcinoma

Advanced Solid Tumor

Therapies

Ceralasertib + Olaparib

Olaparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.